We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+0.24%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.6B
AUM Growth
+$1.47B
Cap. Flow
+$1.6B
Cap. Flow %
9.12%
Top 10 Hldgs %
17.57%
Holding
1,695
New
602
Increased
310
Reduced
364
Closed
414

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$207M
2
PFE icon
Pfizer
PFE
+$171M
3
JNJ icon
Johnson & Johnson
JNJ
+$140M
4
SSNC icon
SS&C Technologies
SSNC
+$132M
5
MSFT icon
Microsoft
MSFT
+$131M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$158M
2
META icon
Meta Platforms (Facebook)
META
+$120M
3
BKNG icon
Booking.com
BKNG
+$106M
4
MRK icon
Merck
MRK
+$93.9M
5
IDXX icon
Idexx Laboratories
IDXX
+$92.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.54%
2 Technology 21.21%
3 Consumer Discretionary 13.38%
4 Industrials 12.45%
5 Financials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CEVA icon
951
CEVA Inc
CEVA
$1.08B
$219K ﹤0.01%
+7,322
New +$213K
VSH icon
952
Vishay Intertechnology
VSH
$5.43B
$219K ﹤0.01%
+12,961
New +$213K
PGRE
953
DELISTED
Paramount Group
PGRE
$217K ﹤0.01%
+16,265
New +$219K
LGTY
954
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$214K ﹤0.01%
+14,238
New +$200K
SVRA icon
955
Savara
SVRA
$1.19B
$213K ﹤0.01%
80,304
– –
SASR
956
DELISTED
Sandy Spring Bancorp Inc
SASR
$209K ﹤0.01%
+6,219
New +$216K
VLRS
957
Controladora Vuela Compania de Aviacion
VLRS
$939M
$208K ﹤0.01%
+20,788
New +$200K
MDCO
958
DELISTED
Medicines Co
MDCO
$208K ﹤0.01%
+4,165
New +$166K
BECN
959
DELISTED
Beacon Roofing Supply, Inc.
BECN
$205K ﹤0.01%
6,108
-8,685
-59% -$294K
CRTO icon
960
Criteo S.A. Ordinary Shares
CRTO
$923M
$201K ﹤0.01%
10,700
-114,809
-91% -$2.16M
LOPE icon
961
Grand Canyon Education
LOPE
$3.98B
$196K ﹤0.01%
+1,996
New +$238K
TDY icon
962
Teledyne Technologies
TDY
$32B
$193K ﹤0.01%
+599
New +$179K
AFMD
963
DELISTED
Affimed
AFMD
$192K ﹤0.01%
+6,525
New +$194K
KFRC icon
964
Kforce
KFRC
$1.06B
$192K ﹤0.01%
+5,079
New +$175K
SRPT icon
965
Sarepta Therapeutics
SRPT
$1.77B
$192K ﹤0.01%
2,541
-22,226
-90% -$2.62M
VEDL
966
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$191K ﹤0.01%
+22,127
New +$190K
TCF
967
DELISTED
TCF Financial Corporation Common Stock
TCF
$189K ﹤0.01%
4,972
-69,580
-93% -$2.77M
ACRE
968
Ares Commercial Real Estate
ACRE
$270M
$188K ﹤0.01%
+12,317
New +$188K
HTH icon
969
Hilltop Holdings
HTH
$2.24B
$188K ﹤0.01%
+7,860
New +$180K
DBD
970
DELISTED
Diebold Nixdorf Incorporated
DBD
$188K ﹤0.01%
+16,825
New +$199K
NUVA
971
DELISTED
NuVasive, Inc.
NUVA
$187K ﹤0.01%
2,943
-4,880
-62% -$305K
FARO
972
DELISTED
Faro Technologies
FARO
$186K ﹤0.01%
+3,843
New +$194K
COLM icon
973
Columbia Sportswear
COLM
$2.94B
$184K ﹤0.01%
1,894
-8,610
-82% -$851K
FRC
974
DELISTED
First Republic Bank
FRC
$184K ﹤0.01%
+1,899
New +$180K
MEDP icon
975
Medpace
MEDP
$16.5B
$180K ﹤0.01%
2,142
-5,700
-73% -$431K
37 38
39
40 41

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q3 2019 Portfolio in Review

As of Q3 2019, Marshall Wace North America held 1,695 positions worth $17.6B, up 9.1% from $16.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $1.6B of net new capital in Q3 2019, opening 602 new positions and adding to 310 existing holdings. Its largest new stake was Johnson & Johnson: 1,065,531 shares worth $138M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $120M trimmed.

  • Marshall Wace North America's largest Q3 2019 buy was Johnson & Johnson: 1,065,531 shares worth $138M.
  • Marshall Wace North America added most to Apple in Q3 2019, an estimated $207M increase.
  • Marshall Wace North America's biggest Q3 2019 reduction was Meta Platforms (Facebook), cutting an estimated $120M.
  • Marshall Wace North America fully exited Abbott in Q3 2019, selling an estimated $158M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $17.6B portfolio in Q3 2019.
  • Marshall Wace North America opened 602 new positions and closed 414 in Q3 2019.
  • Marshall Wace North America's portfolio value rose 9.1% quarter-over-quarter to $17.6B.

Based on Marshall Wace North America's 13F filing for Q3 2019, filed 14 Nov 2019.